Search research articles
Contact Us
Filters
Showing results (441-450 of 594) with videos related to
Page
of 60
Sort By:
Chest
|
November 20, 2020
Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations
Audra J Schwalk, David E Ost, Sahara N Saltijeral, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2009
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer
F Christopher Holsinger, Merrill S Kies, Eduardo M Diaz, et al.
Cancer Chemotherapy and Pharmacology
|
October 29, 2013
Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)
Yoon-Koo Kang, Jeong Hwan Yook, Heung-Moon Chang, et al.
Progress in Biophysics and Molecular Biology
|
November 3, 2010
Theoretical models for coronary vascular biomechanics: progress & challenges
Sarah L Waters, Jordi Alastruey, Daniel A Beard, et al.
Plos One
|
July 7, 2011
Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells
Yun-Ju Chen, Wei-Chien Huang, Ya-Ling Wei, et al.
Cancer Research
|
July 5, 2011
Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapy
Fei Yang, Ximing Tang, Erick Riquelme, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 29, 2019
Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship
James C H Chow, Ka-Man Cheung, Kwok-Hung Au, et al.
Advances in Therapy
|
July 9, 2021
Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II Trial
Renata Ferrarotto, Luana G Sousa, Yun Qing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial
Merrill S Kies, Floyd Christopher Holsinger, J Jack Lee, et al.
The Lancet. Oncology
|
March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)
Emily Alger, Antoine Regnault, Amylou C Dueck, et al.
Page
of 60
Search research articles
Search
Showing results (441-450 of 594) with videos related to
Sort By:
Page
of 60
Chest
|
November 20, 2020
Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations
Audra J Schwalk, David E Ost, Sahara N Saltijeral, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2009
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer
F Christopher Holsinger, Merrill S Kies, Eduardo M Diaz, et al.
Cancer Chemotherapy and Pharmacology
|
October 29, 2013
Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)
Yoon-Koo Kang, Jeong Hwan Yook, Heung-Moon Chang, et al.
Progress in Biophysics and Molecular Biology
|
November 3, 2010
Theoretical models for coronary vascular biomechanics: progress & challenges
Sarah L Waters, Jordi Alastruey, Daniel A Beard, et al.
Plos One
|
July 7, 2011
Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells
Yun-Ju Chen, Wei-Chien Huang, Ya-Ling Wei, et al.
Cancer Research
|
July 5, 2011
Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapy
Fei Yang, Ximing Tang, Erick Riquelme, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 29, 2019
Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship
James C H Chow, Ka-Man Cheung, Kwok-Hung Au, et al.
Advances in Therapy
|
July 9, 2021
Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II Trial
Renata Ferrarotto, Luana G Sousa, Yun Qing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial
Merrill S Kies, Floyd Christopher Holsinger, J Jack Lee, et al.
The Lancet. Oncology
|
March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)
Emily Alger, Antoine Regnault, Amylou C Dueck, et al.
Page
of 60